title: Targeting tryptophan hydroxylase 2 in affective disorder.
abstract: BACKGROUND
  Serotonin (5-HT) has been implicated in several psychiatric disorders including schizophrenia, depressive disorder and suicide. The key and rate limiting enzyme of 5-HT synthesis is tryptophan hydroxylase 2 (TPH2).
  
  
  METHODS
  The association between TPH2 and affective disorders as well as future vistas of its potential clinical targeting: i) TPH2 in the regulation of 5-HT-dependent behavior, ii) TPH2 gene polymorphism and human behavior, iii) TPH2 and sensitivity to antidepressants and iv) effect of dietary tryptophan manipulation on affective behavior are described.
  
  
  RESULTS
  The main conclusions of the review are: i) there is an association between TPH2 and genetically defined behavioral variations, ii) the haplotypes, including some human TPH2 gene SNPs, can predict the risk of affective disorders and the sensitivity to antidepressant therapeutics, iii) mutations decreasing TPH2 activity produce negative effects on behavior and, possibly, on survival, iv) the effect of dietary tryptophan manipulations on human mood and behavior is modest compared with that of inhibitors of 5-HT transporter and monoamine oxidase.
  
  
  CONCLUSIONS
  More comprehensive study of TPH2 genetics is needed to increase the clinical value of the enzyme as a predictor of affective disorder risk and efficacy of antidepressant drugs.
authors.affiliation: Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences, Novosibirsk, Russia. npopova@bionet.nsc.ru
authors.forename: Nina K
authors.initials: NK
authors.lastname: Popova
authors.forename: Alexander V
authors.initials: AV
authors.lastname: Kulikov
mesh_terms: D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology; D015195:Drug Design; D004351:Drug Resistance / Q000235:genetics; D004791:Enzyme Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D020022:Genetic Predisposition to Disease; D006801:Humans; D019964:Mood Disorders / Q000178:diet therapy / Q000188:drug therapy* / Q000378:metabolism*; D011110:Polymorphism, Genetic; D011619:Psychotropic Drugs / Q000494:pharmacology* / Q000627:therapeutic use; D012701:Serotonin / Q000378:metabolism; D014364:Tryptophan / Q000008:administration & dosage; D014365:Tryptophan Hydroxylase / Q000037:antagonists & inhibitors* / Q000235:genetics / Q000378:metabolism*
chemical_list: D000928:Antidepressive Agents; D004791:Enzyme Inhibitors; D011619:Psychotropic Drugs; D012701:Serotonin; D014364:Tryptophan; C494784:TPH2 protein, human; D014365:Tryptophan Hydroxylase